Status:
RECRUITING
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Lead Sponsor:
National Medical Research Center for Therapy and Preventive Medicine
Collaborating Sponsors:
Moscow State Clinical Hospital named after V.V. Veresaev
Conditions:
Heart Failure With Preserved Ejection Fraction
Obesity, Mild
Eligibility:
All Genders
40-80 years
Brief Summary
Study Aim is creation of the Hospital Register of patients with heart failure with preserved ejection fraction (HFpEF) for a comprehensive assessment of the influence of gender characteristics, clinic...
Detailed Description
THE RELEVANCE OF RESEARCH Identifying patients with heart failure with preserved ejection fraction (HFpEF) represents a significant public health challenge. In a significant proportion of patients wit...
Eligibility Criteria
Inclusion
- All patients hospitalized with a clinical picture of acute decompensation of heart failure (shortness of breath, orthopnea, clinical signs of "cardiac asthma" and/or "pulmonary edema") in the city clinical hospital named after. V.V. Veresaeva, Moscow. Patients with a confirmed diagnosis in accordance with instrumental (EchoCG) and/or laboratory criteria.
Exclusion
- Refusal to sign informed consent to participate in a clinical trial and to process personal data.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06114498
Start Date
September 1 2023
End Date
December 31 2026
Last Update
February 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Moscow State Clinical Hospital named after V.V. Veresaev
Moscow, Russia
2
National Medical Research Center for Therapy and Preventive Medicine
Moscow, Russia